Publication | Closed Access

Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines

Breast OncologyUncertain SignificanceMedicineGenetic EpidemiologyPathologyGynecologyCancer GenomicsBreast CancerHereditary Breast/ovarian CancerCancer GeneticsBrca2 VariantsOncologyPublic HealthVariant InterpretationOvarian Cancer